Genetic associations with valvular calcification and aortic stenosis

New England Journal of Medicine

Volumn 368, Issue 6, 2013, Pages 503-512

  Thanassoulis, George ^a,c   Campbell, Catherine Y ^f   Owens, David S ^j   Smith, J Gustav ^q,r   Smith, Albert V ^l,m   Peloso, Gina M ^c,e   Kerr, Kathleen F ^j   Pechlivanis, Sonali ^s   Budoff, Matthew J ^h   Harris, Tamara B ⁿ   Malhotra, Rajeev ^e   O'Brien, Kevin D ^j   Kamstrup, Pia R ^w   Nordestgaard, Børge G ^x   Tybjaerg Hansen, Anne ^x   Allison, Matthew A ^k   Aspelund, Thor ^l,m   Criqui, Michael H ^k   Heckbert, Susan R ^j   Hwang, Shih Jen ^b,c   Liu, Yongmei ⁱ   Sjogren, Marketa ^r   Van Der Pals, Jesper ^r   Kälsch, Hagen ^t   Mühleisen, Thomas W ^u   Nöthen, Markus M ^u,v   Cupples, L Adrienne ^c,d   Caslake, Muriel ^o   Di Angelantonio, Emanuele ^p   Danesh, John ^p   Rotter, Jerome I ^g   Sigurdsson, Sigurdur ^l   Wong, Quenna ^j   Erbel, Raimund ^t   Kathiresan, Sekar ^c,e   Melander, Olle ^r   Gudnason, Vilmundur ^l,m   O'Donnell, Christopher J ^b,c,e   Post, Wendy S ^f   more..

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c FRAMINGHAM HEART STUDY   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g CEDARS SINAI MEDICAL CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ WAKE FOREST SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF WASHINGTON   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l Iceland Heart Association   (Iceland)

^m UNIVERSITY OF ICELAND   (Iceland)

ⁿ NATIONAL INSTITUTE ON AGING   (United States)

^o UNIVERSITY OF GLASGOW   (United Kingdom)

^p UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^q BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^r LUND UNIVERSITY   (Sweden)

^s UNIVERSITY OF DUISBURG ESSEN   (Germany)

^t West German Heart Center   (Germany)

^u Life and Brain Center   (Germany)

^v UNIVERSITY OF BONN   (Germany)

^w University of Copenhagen   (Denmark)

^x UNIVERSITY OF COPENHAGEN   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN A;

ADULT; AFRICAN AMERICAN; AGED; AORTA STENOSIS; AORTA VALVE CALCIFICATION; AORTA VALVE REPLACEMENT; ARTICLE; ASIAN AMERICAN; CALCIFICATION; CAUCASIAN; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DENMARK; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HISPANIC; HUMAN; IL1F9 GENE; LPA GENE; MAJOR CLINICAL STUDY; MALE; MITRAL ANNULAR CALCIFICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN; VALVULAR HEART DISEASE;

EID: 84873513160     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1109034     Document Type: Article

References (47)

1. Carabello BA, Paulus WJ. Aortic stenosis. Lancet 2009;373:956-66.
2. Cosmi JE, Kort S, Tunick PA, et al. The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening. Arch Intern Med 2002;162:2345-7.
3. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341:142-7.
4. Fox CS, Vasan RS, Parise H, et al. Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study. Circulation 2003;107:1492-6.
5. Bella JN, Tang WH, Kraja A, et al. Genome-wide linkage mapping for valve calcification susceptibility loci in hypertensive sibships: the Hypertension Genetic Epidemiology Network Study. Hypertension 2007;49:453-60.
6. Psaty BM, O'Donnell CJ, Gudnason V, et al. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circulation 2009;2:73-80.
7. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health 1951;41:279-81.
8. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol 1979;110:281-90.
9. Bild DE, Bluemke DA, Burke GL, et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol 2002;156:871-81.
10. Harris TB, Launer LJ, Eiriksdottir G, et al. Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. Am J Epidemiol 2007;165:1076-87.
11. Schmermund A, Möhlenkamp S, Stang A, et al. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Am Heart J 2002;144:212-8.
12. Berglund G, Elmstahl S, Janzon L, Larsson SA. The Malmo Diet and Cancer Study: design and feasibility. J Intern Med 1993;233:45-51.
13. Schnohr P, Jensen G, Lange P, Scharling H, Appleyard M. The Copenhagen City Heart Study - Østerbroundersøgelsen: tables with data from the third examination, 1991-1994. Eur Heart J 2001;3:Suppl:H1-H83.
14. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-32.
15. Carr JJ, Nelson JC, Wong ND, et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 2005;234:35-43.
16. Hoffmann U, Massaro JM, Fox CS, Manders E, O'Donnell CJ. Defining normal distributions of coronary artery calcium in women and men (from the Framingham Heart Study). Am J Cardiol 2008;102:1136-41.
17. Musunuru K, Lettre G, Young T, et al. Candidate Gene Association Resource (CARe): design, methods, and proof of concept. Circ Cardiovasc Genet 2010;3:267-75.
18. Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007;39:906-13.
19. International HapMap Consortium. A haplotype map of the human genome. Nature 2005;437:1299-320.
20. Clayton D, McKeigue PM. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 2001;358:1356-60.
21. Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000;343:611-7.
22. Tracy RP. "Deep phenotyping": characterizing populations in the era of genomics and systems biology. Curr Opin Lipidol 2008;19:151-7.
23. Thanassoulis G, Massaro JM, Cury R, et al. Associations of long-term and early adult atherosclerosis risk factors with aortic and mitral valve calcium. J Am Coll Cardiol 2010;55:2491-8.
24. Owens DS, Katz R, Johnson E, et al. Interaction of age with lipoproteins as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Arch Intern Med 2008;168:1200-7.
25. Horne BD, Camp NJ, Muhlestein JB, Cannon-Albright LA. Evidence for a heritable component in death resulting from aortic and mitral valve diseases. Circulation 2004;110:3143-8.
26. Probst V, Le Scouarnec S, Legendre A, et al. Familial aggregation of calcific aortic valve stenosis in the western part of France. Circulation 2006;113:856-60.
27. Garg V, Muth AN, Ransom JF, et al. Mutations in NOTCH1 cause aortic valve disease. Nature 2005;437:270-4.
28. Ortlepp JR, Hoffmann R, Ohme F, Lauscher J, Bleckmann F, Hanrath P. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 2001;85:635-8.
29. Novaro GM, Sachar R, Pearce GL, Sprecher DL, Griffin BP. Association between apolipoprotein E alleles and calcific valvular heart disease. Circulation 2003;108:1804-8.
30. Nordström P, Glader CA, Dahlén G, et al. Oestrogen receptor α gene polymorphism is related to aortic valve sclerosis in postmenopausal women. J Intern Med 2003;254:140-6.
31. Ortlepp JR, Schmitz F, Mevissen V, et al. The amount of calcium-deficient hexagonal hydroxyapatite in aortic valves is influenced by gender and associated with genetic polymorphisms in patients with severe calcific aortic stenosis. Eur Heart J 2004;25:514-22.
32. Gaudreault N, Ducharme V, Lamontagne M, et al. Replication of genetic association studies in aortic stenosis in adults. Am J Cardiol 2011;108:1305-10.
33. Morgan TM, Krumholz HM, Lifton RP, Spertus JA. Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA 2007;297:1551-61. [Erratum, JAMA 2007;298:973.]
34. Nordestgaard BG, Chapman MJ, Ray K, et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 2010;31:2844-53.
35. Clarke R, Peden JF, Hopewell JC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 2009;361:2518-28.
36. Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 2009;301:2331-9.
37. Kreuzer J, Lloyd MB, Bok D, et al. Lipoprotein (a) displays increased accumulation compared with low-density lipoprotein in the murine arterial wall. Chem Phys Lipids 1994;67-68:175-90.
38. Tsimikas S, Brilakis ES, Miller ER, et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med 2005;353:46-57.
39. Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. A potential basis for the thrombotic risks associated with lipoprotein(a). Nature 1989;339:301-3.
40. Nielsen LB, Stender S, Kjeldsen K, Nordestgaard BG. Specific accumulation of lipoprotein(a) in balloon-injured rabbit aorta in vivo. Circ Res 1996;78:615-26.
41. Bozbas H, Yildirir A, Atar I, et al. Effects of serum levels of novel atherosclerotic risk factors on aortic valve calcification. J Heart Valve Dis 2007;16:387-93.
42. Glader CA, Birgander LS, Soderberg S, et al. Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis. Eur Heart J 2003;24:198-208.
43. Gotoh T, Kuroda T, Yamasawa M, et al. Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study). Am J Cardiol 1995;76:928-32.
44. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. J Am Coll Cardiol 1997;29:630-4.
45. O'Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol 1996;16:523-32.
46. Capuzzi DM, Guyton JR, Morgan JM, et al. Efficacy and safety of an extended-release niacin (Niaspan): a long-term study. Am J Cardiol 1998;82:74U-81U.
47. Merki E, Graham M, Taleb A, et al. Antisense oligonucleotide lowers plasma levels of apolipoprotein (a) and lipoprotein (a) in transgenic mice. J Am Coll Cardiol 2011;57:1611-21.